![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, April 25, 2021 11:25:37 AM
++++++++++++++++++++++++++++++++++++++
Antiviral Granted Emergency Approval to Treat Moderate COVID-19 Adult Patients in India
April 24, 2021 - 2:48 pm CDT - Coronavirus Today
India-based Zydus Cadila announced that the company had received Restricted Emergency Use Approval from the Drug Controller General of India to use ‘Virafin,’ Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
When a single-dose subcutaneous regimen is administered early on during COVID-19, Virafin will help patients recover faster and avoid much of the complications, said the company's press statement issued on April 23, 2021.
In the multicentric phase 3 trial conducted in 20-25 centers across India, Virafin had shown the lesser need for supplemental oxygen, clearly indicating that it could control respiratory distress and failure, which has been one of the major challenges in treating COVID-19.
The Phase III trials demonstrated that a higher proportion of patients in the PegIFN arm showed a two-point statistically significant clinical improvement (WHO 7-point ORDINAL SCALE) on day 8 as compared to the Standard of Care (SOC arm) (80.36% vs. 68.18%).
Speaking on the development, Dr. Sharvil Patel, Managing Director, Cadila Healthcare Limited, commented, “The fact that we can offer a therapy which significantly reduces the viral load when given early on can help in better disease management. It comes at a much-needed time for patients, and we will continue to provide them access to critical therapies in this battle against COVID-19.”
Virafin will be available on the prescription of a medical specialist for use in a hospital / institutional setup in India.
Zydus Cadila is a leading Indian pharmaceutical company located in Ahmedabad and is a fully integrated, global healthcare provider.
—Staff Review
Medical Review byDanielle Reiter, RN
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM